Foster Dykema Cabot & CO Inc Amgen Inc Transaction History
Foster Dykema Cabot & CO Inc
- $827 Million
- Q3 2023
A detailed history of Foster Dykema Cabot & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Foster Dykema Cabot & CO Inc holds 614 shares of AMGN stock, worth $158,890. This represents 0.02% of its overall portfolio holdings.
Number of Shares
614
Previous 564
8.87%
Holding current value
$158,890
Previous $125,000
32.0%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,126Shares Held
409MCall Options Held
7.56MPut Options Held
7.2M-
Vanguard Group Inc Valley Forge, PA52.4MShares$13.6 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$11.9 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$7.59 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$3.8 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$3.69 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $138B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...